Department of Psychology and Behavioral Science, Aarhus University, Bartholins Allé 9, 8000 C, Aarhus, Denmark.
Breast Cancer Res Treat. 2013 Apr;138(3):675-90. doi: 10.1007/s10549-013-2503-4. Epub 2013 Apr 4.
Persistent pain after breast cancer treatment is prevalent, and not all patients respond sufficiently to pharmacological treatment. Pain is recognized as a multi-dimensional phenomenon, which includes psychological and social components, and several clinical trials have investigated the efficacy of psychosocial interventions on pain in cancer patients and survivors. Our aim was to systematically review and quantify the existing research on the effect of psychosocial interventions on pain in breast cancer patients and survivors. Two independent raters reviewed 474 abstracts for eligibility, leading to the identification of 26 independent and eligible studies published between 1983 and 2012, which were assessed for their methodological quality and subjected to meta-analytic evaluation. A total of 1786 participants were included in the analyses. A statistically significant and robust overall effect size was found across all included studies (Hedges g = 0.37, 95 % CI: 0.20-0.40; p < 0.001). However, the effect size was considerably smaller (0.21), when adjusted for possible publication bias. Furthermore, the results were heterogeneous, and when exploring the sources of heterogeneity, studies of higher methodological quality were found to yield a more conservative effect size (g = 0.21, 95 % CI: 0.02-0.41) than studies of poorer quality (g = 0.65, 95 % CI: 0.25-1.04). The results also indicated that patient educational approaches yielded a larger effect size (g = 0.64) than relaxation-based interventions (g = 0.31, 95 % CI: -0.05-0.67) and supportive group therapy (g = 0.17, 95 % CI: 0.02-0.32). Taken together, while suggestive of psychosocial intervention as an effective tool in the management of pain among breast cancer patients and survivors, the results should be interpreted as preliminary. The methodological quality of the existing research varied considerably, and only few studies had selected patients on the basis of the presence of pain and included pain as the primary outcome.
乳腺癌治疗后持续性疼痛较为常见,并非所有患者对药物治疗均有充分反应。疼痛被认为是一种多维现象,包括心理和社会成分,多项临床试验已调查心理社会干预对癌症患者和幸存者疼痛的疗效。我们旨在系统地回顾和量化现有的关于心理社会干预对乳腺癌患者和幸存者疼痛影响的研究。两位独立的评估者对 474 篇摘要进行了资格审查,确定了 1983 年至 2012 年间发表的 26 项独立且符合条件的研究,评估了这些研究的方法学质量,并进行了荟萃分析评价。共有 1786 名参与者纳入分析。所有纳入研究的总体效应大小均具有统计学意义且稳健(Hedges g = 0.37,95%CI:0.20-0.40;p < 0.001)。然而,当调整可能的发表偏倚时,效应大小明显较小(0.21)。此外,结果存在异质性,当探索异质性来源时,发现方法学质量较高的研究得出的效应大小较为保守(g = 0.21,95%CI:0.02-0.41),而方法学质量较差的研究得出的效应大小较大(g = 0.65,95%CI:0.25-1.04)。结果还表明,患者教育方法的效应大小较大(g = 0.64),而放松干预的效应大小较小(g = 0.31,95%CI:-0.05-0.67),支持性团体治疗的效应大小较小(g = 0.17,95%CI:0.02-0.32)。总的来说,虽然提示心理社会干预是乳腺癌患者和幸存者疼痛管理的有效工具,但结果应被视为初步结果。现有研究的方法学质量差异较大,只有少数研究根据疼痛的存在选择患者,并将疼痛作为主要结局纳入研究。